Moreover, our data also suggest that transcriptional and translational mechanisms may underlie BACE1 elevation in response to adverse stressors, supporting the idea that therapeutic interventions aimed at suppressing stress-related signaling pathways (e.g., reduction of glucocorticoids or eIF2α phosphorylation) may be beneficial for slowing down AD progression. This evidence concerns the gene BACE1 and Alzheimer disease.